Replies to post #440 on Onconova Therapeutics Inc (ONTX)
03/05/18 4:46 PM
03/06/18 10:48 AM
03/06/18 3:32 PM
"We are delighted to partner with Pint Pharma, which has a wide footprint in South and Central America, and view this license agreement as further validation of the potential of rigosertib for the treatment of MDS," commented $ONTX CEO https://t.co/uDTprbBEEB
— OnconovaTherapeutics (@Onconova_ONTX) March 6, 2018
06/07/18 11:08 AM
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |